Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Arch Intern Med 170(11):977-85 (2010) PMID 20548011
Guidelines recommend screening for cervical cancer among women 30 years or older 3 years after a normal Papanicolaou test (hereinafter referred to as Pap test) result or a combined normal screening result (normal Pap/negative human papillomavirus [HPV] test results). We assessed reported recommendations by US primary care physicians (PCPs) on screening intervals that incorporate HPV cotesting compared with Pap testing alone.
DOI: 10.1001/archinternmed.2010.134
Version: za2963e q8zad q8zb8 q8zcb q8zd6 q8zeb q8zf0 q8zgf